Bioinfra

Developer of blood-based in vitro cancer screening technology

placeSeoul, Seoul, South Korea calendar_todayFounded 2001 groups27 employees language bioinfra.co.kr

Innovation

32 patent families (7 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities, Operations & transport; filing pace slowing. Cited 262 times.

YearFilings
20127
201312
20143
20152
20161
20172
20181
20191
20201
20211
20231

Investor mix

6 investors on record; lead investors include Ryan Vehicles, Korea Investment Holdings.

Investor typeCountShare
Venture capital467%
Bank & private debt117%
Other / undisclosed117%
Coming soon